The Location Analysis on Dry Port of the Inland in Jinan City
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Efficacy Evaluation on the Color Doppler Ultrasound, Multislice Spiral CT Combined with Serum Markers in Diagnosis of Primary Hepatic Carcinoma
Iran J Public Health, Vol. 50, No.8, Aug 2021, pp.1603-1612 Original Article Efficacy Evaluation on the Color Doppler Ultrasound, Multislice Spiral CT Combined with Serum Markers in Diagnosis of Primary Hepatic Carcinoma Xiaolan Zhao 1, Yifang Xia 2, Chunjing Li 2, *Dapeng Wang 3 1. Department of Ultrasound, Yantaishan Hospital, Yantai 264000, China 2. Department of Imaging, Zhangqiu District People’s Hospital, Jinan 250200, China 3. Department of Imaging, the Affiliated Hospital of China University of Petroleum (East China), Qingdao 266580, China *Corresponding Author: Email: [email protected] (Received 22 Nov 2020; accepted 09 Dec 2020) Abstract Background: The efficacy of color Doppler ultrasound, multislice spiral CT combined with serum alpha- fetoprotein (AFP) and alpha-fetoprotein heterogeneity (AFP-L3) in the diagnosis of primary hepatic carcino- ma was evaluated. Methods: Seventy-nine patients with primary hepatic carcinoma (PHC group) and 50 patients with benign liver lesions (benign control group) admitted in Yantaishan Hospital (Yantai, China) from January 2016 to December 2018 were selected. The liver was scanned by color Doppler ultrasound and multiple multislice spi- ral CT. The serum AFP and AFP-L3 levels were detected by electrochemiluminescence. The value of color Doppler ultrasound, multislice spiral CT combined with serum AFP and AFP-L3 in diagnosis of primary liver cancer was retrospectively analyzed. Results: The color Doppler flow imaging (CDFI) showed a high-speed and high-resistance spectrum. The serum AFP and AFP-L3 levels of patients with primary hepatic carcinoma were significantly higher than those of the benign control group were (U=138.000 and 155.500, P=0.000 and 0.000), P<0.01. -
Property Valuation Report
THIS DOCUMENT IS IN DRAFT FORM, INCOMPLETE AND SUBJECT TO CHANGE AND THAT THE INFORMATION MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT APPENDIX III PROPERTY VALUATION REPORT The following is the text of a letter, summary of values and valuation certificates prepared for the purpose of incorporation in this document received from AVISTA Valuation Advisory Limited, an independent valuer, in connection with its valuation as at 30 April 2021 of the property interest held by the Group. [*] 2021 The Board of Directors Runhua Property Technology Development Inc 6th Floor, Building No. 1 Lemeng Center, No. 28988 Jingshi Road, Huaiyin District, Jinan City, Shandong Province, the People’s Republic of China (the “PRC”) Dear Sirs / Madams, INSTRUCTIONS In accordance with the instructions of Runhua Property Technology Development Inc (the “Company”) and its subsidiaries (hereinafter together referred to as the “Group”) for us to carry out the valuation of the property interests located in the PRC held and rented by the Group. We confirm that we have carried out inspection, made relevant enquiries and searches and obtained such further information as we consider necessary for the purpose of providing you with our opinion of the market value of the property interests as at 30 April 2021 (the “Valuation Date”). VALUATION STANDARDS In valuing the property interests, we have complied with all the requirements set out in Chapter 5 and Practise Note 12 of the Rules Governing the Listing of Securities issued by The Stock Exchange of Hong Kong Limited (the “Listing Rules”), RICS Valuation — Global Standards 2020 published by the Royal Institution of Chartered Surveyors (“RICS”) and the International Valuation Standards published from time to time by the International Valuation Standards Council. -
Free PDF Download
European Review for Medical and Pharmacological Sciences 2021; 25: 3226-3234 LncRNA PRNCR1 aggravates the malignancy of oral squamous cell carcinoma by regulating miR-326/FSCN1 axis D.-K. LIU1, Y.-J. LI2, B. TIAN3, H.-M. SUN4, Q.-Y. LI5, B.-F. REN6 1Department of Stomatology, Yantaishan Hospital, Yantai, Shandong Province, China 2Department of Emergency Internal Medicine, Qingdao Municipal Hospital, Qingdao, Shandong Province, China 3Department of Clinical Laboratory Medicine, People’s Hospital of Rizhao, Rizhao, Shandong Province, China 4Hospital Infection-Control Department, Zhangqiu District People’s Hospital, Jinan, Shandong Province, China 5Imaging Center, Zhangqiu District People’s Hospital, Jinan, Shandong Province, China 6Medical Insurance Department, Zhangqiu District People’s Hospital, Jinan, Shandong Province, China Dekuan Liu and Yongjun Li contributed equally Abstract. – OBJECTIVE: The important regu- Introduction latory mechanism of lncRNA PRNCR1 has been emphasized in malignant tumors. However, the In recent years, oral cancer has been threaten- role of lncRNA PRNCR1 remains unclear in oral ing our health and is one of the most serious oral squamous cell carcinoma (OSCC). The purpose diseases. Oral cancer is more common in men, of this study is to reveal the role of lncRNA PRN- and the most common is oral squamous cell car- CR1 in OSCC. 1 PATIENTS AND METHODS: RT-qPCR was cinoma (OSCC) . The etiology of oral cancer is used to detect mRNA expression. The function- unclear and may be related to long-term smoking al mechanism of lncRNA PRNCR1 in OSCC was and alcohol abuse, poor oral hygiene, malnu- investigated by CCK-8, transwell and Luciferase trition, leukoplakia and erythema2. -
Corporate Information
CORPORATE INFORMATION Registered office Units 2102-2103 China Merchants Tower Shun Tak Centre 168-200 Connaught Road Central Hong Kong Principal place of business 165 Yingxiongshan Road in China Jinan, Shandong Province China 250002 Company’s website www.sinotruk.com (The information as contained in the website does not form part of this prospectus) Company secretaries Tong Jingen App1A.3 Kwok Ka Yiu (CPA, FCCA) Authorized representatives Tong Jingen A2, 17th Floor Park View Court 1 Lyttelton Road Hong Kong Kwok Ka Yiu (CPA, FCCA) Room 1701, Block 40 Heng Fa Chuen Chai Wan Hong Kong Qualified accountant Kwok Ka Yiu (CPA, FCCA) Board audit committee Lin Zhijun Chen Zheng Ouyang Minggao Wang Guangxi Tong Jingen Board remuneration committee Chen Zheng Lin Zhijun Li Xianyu Wei Zhihai Tong Jingen 57 CORPORATE INFORMATION Board strategy and investment Ma Chunji committee Cai Dong Shao Qihui Ouyang Minggao Hu Zhenghuan Wang Haotao Wang Shanpo Share Registrar Computershare Hong Kong Investor Services Limited Shops 1712-1716, 17/F Hopewell Centre 183 Queen’s Road East Wan Chai Hong Kong Principal bankers Industrial and Commercial Bank of China Jinan Branch, Tianqiao Sub-branch 7 Dongxidanfeng Street Tianqiao District Jinan, Shandong Province The PRC Agricultural Bank of China Jinan Branch, Huaiyin Sub-branch No. 138 Jingxi Road Jinan, Shandong Province The PRC Bank of China Jinan Branch No. 22 Liyuan Street Jinan, Shandong Province The PRC China Construction Bank Jinan Branch, Tianqiao Sub-branch No. 125 Ji Luo Road Jinan, Shandong Province The PRC 58. -
2012 Summarized Annual Report of Qilu Bank Co., Ltd. (The Annual Report Is Prepared in Chinese and English
2012 Summarized Annual Report of Qilu Bank Co., Ltd. (The annual report is prepared in Chinese and English. English translation is purely for reference only. Should there be any inconsistencies between them; the report in Chinese shall prevail.) Ⅰ. General Introduction ()Ⅰ Legal Name in Chinese:齐鲁银行股份有限公司 (Abbreviation: 齐鲁银行 ) Legal Name in English: QiLu Bank Co., Ltd. (Ⅱ ) Legal Representative: Wang Xiaochun (Ⅲ ) Secretary of the Board of Directors: Mao Fangzhu Address: No.176 Shunhe Street, Shizhong District, Jinan City, Shandong Province Tel: 0531-86075850 Fax: 0531-86923511 Email: [email protected] (Ⅳ ) Registered Address: No.176 Shunhe Street, Shizhong District, Jinan City Office Address: No.176 Shunhe Street, Shizhong District, Jinan City Postcode: 250001 Website: http://www.qlbchina.com (Ⅴ ) Newspapers for Information Disclosure: Financial News Website for Information Disclosure: http://www.qlbchina.com Place where copies of the annual report are available at: The Board of Directors' Office of the Bank (Ⅵ ) Other Relevant Information Date of the Initial Registration: 5 June 1996 Address of the Initial Registration: Shandong Administration for Industry and Commerce Corporate Business License Number: 370000018009391 Tax Registration Number: Ludishuiji Zi No.370103264352296 Auditors: Ernst &Young Hua Ming LLP Auditors’ Address: Level 16, Ernst & Young Tower, Oriental Plaza No.1, East Changan Avenue, Dong Cheng District, Beijing, China 1 II. Financial Highlights (I) Main Profit Indicators for the Reporting Period (Group) Unit -
Visa Application – Section 2.5 Detailing Mailing Addresses & Phone Numbers for Locations in China
Visa Application – Section 2.5 Detailing Mailing Addresses & Phone Numbers for Locations in China It is important to note that your travel arrangements are not finalized until you receive your official adoption itinerary. There is a chance that you will be staying at a different hotel than those included below. * = indicates a hotel that is specific to families adopting from the Gansu, Guangdong, Guizhou or Shaanxi province Holiday Inn Hefei Zugong Plaza Hotel (Anhui) (Gansu) 1104 Changjiang Dong Rd, No.543 Donggangxi Road, Hefei 230001 Chengguan District, Phone: 86-551-2206666 Lanzhou, Gansu, China 730000 Phone: 86931-881.9999 Sofitel Hefei Grand Park (Anhui) Mingyuan Xindu Hotel Fanhua Road, Hefei 230601 (Guangxi) Phone: 86-551-2216688 No. 38 Xinming Road, Nanning Phone: 86-771-2118988 Radisson BLU Hotel (Beijing) China Hotel Marriott No. A East Beishanhuan Road, (Guangzhou) Chao Yang District Liu Hua Road, Guangzhou 510015 Phone: 86-10-59223388 Phone: 86-20-86666888 Metro Park Lido Hotel* Novotel Guiyang Downtown (Beijing) (Guizhou) No. 6 Jiangtailu, Chaoyang District, No. 8, Zhanghua North Road Beijing, China 100004 Guiyang, Guizhou 550002 Phone: 8610-64376688 Phone: 86-851-858-1888 Howard Johnson Plaza Wanda Holiday-Inn (Chongqing) (Heilongjiang) International Trade Center, No. 90 Jinwei Road, No.66 Qingnian Rd, 400010 Harbin, 150010 Phone: 86-23-63666666 Phone: 86-451-84226611 JW Marriott Chongqing Crowne Plaza Hotel (Chongqing) (Henan) 77 Qing Nian Road, Yu Zhong District No.115 Jinshui Road, Chongqing Zhengzhou 450003 Phone: 86-23-63888888 Phone: 86-371-65950055 Lakeside Hotel Fengleyuan Hotel (Fujian) (Henan) No. 158 Hubing Road, Fuzhou 350003 North Nanyang Rd Phone: 86-591-87839888 Phone: 86-371-66771188 Hua Yang Plaza Hotel (Henan) No. -
Fujitsu Client Computing Devices Authorized Service Center
Fujitsu Client Computing Devices Authorized Service Center Country: China Issue: 15th May, 2018 Products: CELSIUS, ESPRIMO, LIFEBOOK, STYLISTIC, DISPLAY and Accessories Customer Service / Technical Support Hotline (Local Toll Free): 4008208387 Location Service Provider Address Telephone Business Hours Language 9:00am - 6:00pm English, Anshan Anshang Mingpin Co.,Ltd No.92, 13F, Silong Plaza, Tiedong Area, Anshang, Liaoning (86) 0412 2988356 (Mon - Sat) Mandarin Beijing Digital China Instant Room 203, Zhong Jia Plaza,East Da Zhong Si, Haidian, (86) 010-86470361 9:00am - 6:00pm English, Beijing Technology Service Co.,Ltd Beijing (86) 010-86470362 (Mon - Sat) Mandarin Beijing Digital China Instant Changsha furong district 21 families and better computer city 9:00am - 6:00pm English, Changsha (86) 0731-84152927 Technology Service Co.,Ltd Station Road building B 26 floor, room 2604, 2605 (Mon - Sat) Mandarin Changzhou Juyi Information Room 1011,Building 10, 15-1,Jiuzhou Digital Center, No.99, 9:00am - 6:00pm English, Changzhou (86) 519 85785712 Technology Co.,Ltd West Laodong Road, Tianning Area, Changzhou (Mon - Sat) Mandarin Beijing Digital China Instant A5, 27F, Building A, Digital Plaza, No.1, Siduan, South 9:00am - 6:00pm English, Chengdu Technology Service Co., LTD (86) 028 85482706 People Road, Wuhou Area, Chengdu (Mon - Sat) Mandarin (Chengdu) Chongqing Pinliang Technology The 9 floor shop No. 9-6-1, Taixing computer city bridge in 9:00am - 6:00pm English, Chongqing (86) 023 68794974 Co.,Ltd Chongqing City (Mon - Sat) Mandarin Chaoyang District City, No. 1313 road workers and peasants 9:00am - 6:00pm English, Chuangchun Changchun Ruilian Co.,Ltd (86) 0431 87065663 Changchun Bainaohui Hongqi Street, room 2022 (Mon - Sat) Mandarin Xinglin street in Zhongshan District of Dalian City, No. -
CHINA VANKE CO., LTD.* 萬科企業股份有限公司 (A Joint Stock Company Incorporated in the People’S Republic of China with Limited Liability) (Stock Code: 2202)
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. CHINA VANKE CO., LTD.* 萬科企業股份有限公司 (A joint stock company incorporated in the People’s Republic of China with limited liability) (Stock Code: 2202) 2019 ANNUAL RESULTS ANNOUNCEMENT The board of directors (the “Board”) of China Vanke Co., Ltd.* (the “Company”) is pleased to announce the audited results of the Company and its subsidiaries for the year ended 31 December 2019. This announcement, containing the full text of the 2019 Annual Report of the Company, complies with the relevant requirements of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited in relation to information to accompany preliminary announcement of annual results. Printed version of the Company’s 2019 Annual Report will be delivered to the H-Share Holders of the Company and available for viewing on the websites of The Stock Exchange of Hong Kong Limited (www.hkexnews.hk) and of the Company (www.vanke.com) in April 2020. Both the Chinese and English versions of this results announcement are available on the websites of the Company (www.vanke.com) and The Stock Exchange of Hong Kong Limited (www.hkexnews.hk). In the event of any discrepancies in interpretations between the English version and Chinese version, the Chinese version shall prevail, except for the financial report prepared in accordance with International Financial Reporting Standards, of which the English version shall prevail. -
50L Home Brew Equipment
Jinan Perfect Beer Kits Co.,Ltd Add: 819, No.53, Jiluo Rd., Tianqiao District, Jinan, Shandong, China Tel: +86-531-666 21211 Fax: +86-531-666 21211 Web: www.gstachina.com jihao.en.alibaba.com QUOTATION AND SPECIFICATIONS OF 50l home brew equipment Jinan Perfect Beer Kits Co.,Ltd Add: 819, No.53, Jiluo Rd., Tianqiao District, Jinan, Shandong, China Tel: +86-531-666 21211 Fax: +86-531-666 21211 Web: www.gstachina.com jihao.en.alibaba.com 1.Quotation: All fee of FOB Qingdao is: USD 6610.00 Ocean Freight: ....(check later) 2.Technical Parameters: Condition: New Place of Origin: Shandong China (Mainland) Processing Types: Beer Voltage: 380V.220V.415V.110V.two or three phase(customized) Power(W): 3kw or by your requestion Processing: wort making, beer brewing, beer fermenting Certification: ISO,CE,TUV Warranty: 3 years warranty of tanks Engineers available to service machinery overseas(need After-sales Service Provided: extra charge) cooling way: fermenter cooling jacket control system: Temperature,pressure automatic control Model Number: GSTA-50l homebrew equipment material: SS304 heated way: electric manhole: top Processing: fermenting equipment fermenter cone: 90 degree insulation: 80mm polyurethane Productivity 50L Total weight 170kg ; about 1500kg 100l Outline size 1800*800* 1800mm Brew house 60L Fermenter tank 60L Cold water tank 50L Floor area 1.6m2 Water consumption 150L Malt consumption 10kg Hops consumption 30-60g Yeast consumption 5L or 50g Jinan Perfect Beer Kits Co.,Ltd Add: 819, No.53, Jiluo Rd., Tianqiao District, Jinan, Shandong, China Tel: +86-531-666 21211 Fax: +86-531-666 21211 Web: www.gstachina.com jihao.en.alibaba.com 2. -
Comparative Analysis of GIS-Based Shandong Province Nutritional
Advances in Computer Science Research (ACSR), volume 61 7th International Conference on Education, Management, Computer and Society (EMCS 2017) Atmospheric Temperature Variation and its Causes in Summer of Jinan for 2015 Baohua Zhou1, a*, Zhanhong Liu1, b and Dong Yuan1, c 1Resources and Environmental Institute, University of Jinan, Jinan, China, 250022 [email protected], [email protected], [email protected] *The corresponding author Keywords: Jinan; Temperature variation; Summer; Urban tropical island effect; El Nino Abstract. This paper analyzed spatiotemporal inhomogeneity characteristics and its causes of air temperature based on the observation data of air temperature on June, July, and August in 2015, combined with the geographic information data of Jinan. Research results show the highest average temperature is on July, no extreme temperature, and the spatiotemporal inhomogeneity characteristics of air temperature are similar to other research that is not the effect of El Nino on Jinan in the summer of 2015. The air temperature of the urban district is slightly higher than other suburban areas on July and June in Jinan, but the spatial inhomogeneity of air temperature is not big on August in Jinan. The urban district of Jinan is the highest average temperature throughout the summer of 2015 that is a sign of the urban tropical island effect. Introduction Air temperature as an important part of the natural environment in which human beings live, any change of it will have a profound impact on natural ecosystems and socio-economic systems[1]. Review of the literature revealed the former research almost based on the temperature of many years. -
Circnrip1 Modulates the Mir-515-5P/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma
Drug Design, Development and Therapy Dovepress open access to scientific and medical research Open Access Full Text Article ORIGINAL RESEARCH CircNRIP1 Modulates the miR-515-5p/IL-25 Axis to Control 5-Fu and Cisplatin Resistance in Nasopharyngeal Carcinoma This article was published in the following Dove Press journal: Drug Design, Development and Therapy Junwu Lin1,* Background: The development of drug resistance leads many NPC patients to experience Hong Qin2,* disease relapse following the completion of chemotherapy. It is thus essential that the Yue Han3 mechanistic basis for such chemoresistance be clarified in an effort to identify approaches Xinghua Li4 to sensitizing NPC tumors to treatment with cisplatin and related agents. YuJuan Zhao5 Methods: A qRT-PCR approach was used to measure the expression of circNRIP1 in NPC, while luciferase assays were used to identify interactions with downstream targets of Guangsheng Zhai 6 circNRIP1 activity including miR-515-5p and IL-25. CCK8 assays were also utilized to 1Department of Otolaryngology, Central detect IC50 values for cisplatin and 5-Fu. Hospital, Qingdao, Shandong, People’s Republic of China; 2Department of Results: The expression of circNRIP1 was significantly increased in the serum of chemore Otolaryngology, Women and Children’s sistant NPC patients. At a functional level, we determined that circNRIP1 is able to sequester Hospital, Qingdao, Shandong, People’s miR-515-5p, thereby inhibiting its ability to post-transcriptionally suppress IL-25 expression. Republic of China; 3Department of Urology, Zhangqiu District People’s We observed a significant negative correlation between the expression of miR-515-5p and Hospital, Jinan, Shandong, People’s circNRIP1 in serum samples from chemoresistant NPC patients, consistent with a functional 4 Republic of China; Department of interaction between these two factors. -
Research Article Effect of Entecavir Combined with Adefovir Dipivoxil on Clinical Efficacy and TNF-Α and IL-6 Levels in Patients with Hepatitis B Cirrhosis
Hindawi Journal of Oncology Volume 2021, Article ID 9162346, 5 pages https://doi.org/10.1155/2021/9162346 Research Article Effect of Entecavir Combined with Adefovir Dipivoxil on Clinical Efficacy and TNF-α and IL-6 Levels in Patients with Hepatitis B Cirrhosis Yonghuan Yu ,1 Xinfeng Cui ,2 Jingjing Zhao ,3 Ting Jia ,4 Baofeng Ren ,5 and Xiaoyan Zhang 6 1Department of Blood Transfusion, Yantaishan Hospital, Yantai 264000, China 2Department of Stomatology, Chengyang People’s Hospital, Chengyang 266109, China 3Department of Surgery, Zhangqiu District People’s Hospital, Jinan 250200, China 4Department of Gynaecology, Zhangqiu District People’s Hospital, Jinan 250200, China 5Medical Insurance Department, Zhangqiu District People’s Hospital, Jinan 250200, China 6PIVAS, Weifang People’s Hospital, Weifang 261041, China Correspondence should be addressed to Xiaoyan Zhang; [email protected] Received 3 June 2021; Accepted 17 August 2021; Published 25 August 2021 Academic Editor: Muhammad Wasim Khan Copyright © 2021 Yonghuan Yu et al. -is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Objective. -e purpose of the study was to investigate the effect of entecavir combined with adefovir dipivoxil on clinical efficacy and TNF-α and IL-6 levels in patients with hepatitis B cirrhosis. Methods. A total of 100 patients with hepatitis B cirrhosis admitted to our hospital between January 2018 and June 2019 were randomly selected and divided into the control group (n � 50) and experimental group (n � 50) according to the order of admission.